Join Now

Author Archives: Natalie Themm

KNOWN MEDICINE RAISES $7.2 MILLION SEED ROUND TO ADVANCE DATA FIRST APPROACH TO ORGANOID TECHNOLOGY

By Natalie Themm | Published August 26, 2021

Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.

Posted in BioUtah News | Tagged | Leave a comment

Fluidx Medical Technology’s Innovative Embolic Tumor Treating Device Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference

By Natalie Themm | Published August 26, 2021

Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.

Posted in BioUtah News | Tagged , | Leave a comment

ZIEN Medical Technologies is Expanding

By Natalie Themm | Published August 26, 2021

ZIEN Medical Technologies, of Salt Lake City, Utah, announces the integration of Eclipse Design Innovations, of Woods Cross, Utah, as well as the Grand Opening of their new 16,000 sq foot manufacturing/R&D facility to continue to support the Utah Life Sciences industry. 

Posted in BioUtah News | Tagged | Leave a comment

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelXTM Testing at Primary Care Level

By Natalie Themm | Published August 26, 2021

Renalytix Plc announced the publication of results from an external chronic kidney disease budget impact analysis projecting 5-year savings of $1.1 billion dollars for a population of 100,000 patients with type 2 diabetes (T2DKD) and chronic kidney disease tested with the Renalytix KidneyIntelX™ testing solution. Savings were driven by more effective pharmacy management and appropriate specialist referral compared to current standard of care for patients at high risk for disease progression and kidney failure.

Posted in BioUtah News | Leave a comment

PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®

By Natalie Themm | Published August 24, 2021

PolarityTE, Inc. today provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers, which was filed on July 23, 2021.

Posted in BioUtah News | Tagged | Leave a comment

Perfect Day To Expand Bio Foundry Capabilities in Utah

By Natalie Themm | Published August 19, 2021

The Utah Governor’s Office of Economic Opportunity (Go Utah) is pleased to announce that Perfect Day, Inc. is formally expanding its “biology-as-a-service” arm, Scalable Bio Foundry, Inc. (SBF, Inc.) in Utah, bringing up to 64 new high-paying jobs to the state in the next five years.

Posted in BioUtah News | Tagged , , , | Leave a comment

Javara and Ogden Clinic launch partnership to advance clinical trial access

By Natalie Themm | Published August 19, 2021

Javara and Ogden Clinic are proud to announce the launch of a partnership to integrate industry-sponsored clinical trials at the point of care for Ogden Clinic patients.

Posted in BioUtah News | Tagged , | Leave a comment

VIA CAPITAL announces the launch of Tailwind Business Accelerator

By Natalie Themm | Published August 19, 2021

Tailwind Business Accelerator is giving $50,000 in cash and services to at least 5 companies in its first cohort, starting November 1. Applications close September 17 for this first cohort.

Posted in BioUtah News | Tagged , | Leave a comment

Genomics 101 by Intermountain Precision Genomics

By Natalie Themm | Published August 19, 2021

In a recent article published by Utah Business Magazine, Dr. Lincoln Nadauld, Chief of Precision Health at Intermountain Healthcare, provides an explanation of the genomic world and how precision medicine will be evolving in the future. Intermountain Precision Genomics, a BioUtah member, is located in St. George, Utah and is a world leader in genomics.

Posted in BioUtah News | Tagged , | Leave a comment

Recursion Reports Second Quarter 2021 Financials and Provides Business Updates

By Natalie Themm | Published August 19, 2021

Recursion, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, today reported financial results and business updates for its second quarter ending June 30, 2021.

Posted in BioUtah News | Tagged | Leave a comment

CenExel Clinical Research Acquires Advanced Memory Research Institute

By Natalie Themm | Published August 19, 2021

CenExel announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest Alzheimer’s Disease clinical research site in the Northeast. CenExel AMRI conducts Phase I through Phase IV studies, primarily in Alzheimer’s Disease, Memory Loss, and Dementia research.

Posted in BioUtah News | Tagged | Leave a comment

U.S. SKI & SNOWBOARD CHOOSES R-ZERO AS ITS BIOSAFETY PARTNER TO PROTECT ATHLETES AND STAFF

By Natalie Themm | Published August 19, 2021

U.S. Ski & Snowboard joins the growing list of professional sports organizations, including NBA and NFL teams, using R-Zero’s tech to reduce health risks from COVID-19 and other airborne and surface pathogens

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members